Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease

Table 2 Demographic differences between viral and non-viral groups

	Viral group (n = 110)	Non-viral group (n = 66)	P value
Gender (%) male/female	62.7/37.3	45.5/54.5	0.025
Age (years), mean ± SD	40 ± 14.63	52.47 ± 17.82	< 0.001
ALT (IU/L), median (Q1-Q3)	1055 (516.8-1869)	821 (316-1520)	0.022
Total bilirubin (mg/dL), median (Q1-Q3)	1.57 (0.72-5.15)	2.49 (0.98-5.92)	0.335
AFP (ng/mL), median (Q1-Q3)	8.22 (4.60-18.83)	4.7 (0-7.6)	< 0.001
WBC (/μL), median (Q1-Q3)	5900 (5000-7500)	7200 (5700-9500)	0.003
PLT (103/μL), median (Q1-Q3)	186 (151-251)	206.5 (142-263)	0.543
WT, median (Q1-Q3)	7 (5-8.9)	0 (0-5.4)	< 0.001
Gallbladder wall thickening (%) (Yes/No)	32.7/67.3	30.3/69.7	0.738
Echogenecity (%) (1/0)	30.6/69.4	20.3/79.7	0.142
LN5 (%) (Yes/No)	80.9/19.1	31.8/68.2	< 0.001

Clinical and biochemical characteristics of patients are expressed as median. Data were tested by U test (Mann-Whitney) and Wilcoxon test, and P < 0.05 was judged to be statistically significant. WT: Value of nodal width; Echogenecity: Chronic liver parenchymal change; 1: Positive, 0: Negative; LN5: Nodal width ≥ 5 mm. ALT: Alanine aminotransferase; AFP: α-fetoprotein; PLT: Platelet; WBC: White blood cell.